热门资讯> 正文
Syra Health报告第二季度业绩
2024-08-09 22:39
- Syra Health press release (NASDAQ:SYRA): Q2 GAAP EPS of -$0.21.
- Revenue of $2M (VS. $1M in Q2/2023).
- Gross margins in 2Q24 increased 468 basis points compared to 2Q23.
- Cash balance of $1.6M and no long-term debt.
More on Syra Health Corp.
- Syra Health Corp. (SYRA) Q1 2024 Earnings Call Transcript
- Syra Health gets $5.8 million contract to train Indiana health workers
- Syra Health reports Q1 results
- Historical earnings data for Syra Health Corp.
- Financial information for Syra Health Corp.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
